Brazil vs Singapore: Coverage of the human papillomavirus vaccine
Brazil
72
in 2025
Singapore
71
in 2025
Brazil rank
36th
Singapore rank
39th
Coverage of the human papillomavirus vaccine over time
- Brazil
- Singapore
How they compare
Brazil currently reports 72 against 71 in Singapore, a difference of 1.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Brazil ahead.
Brazil ranks 36th and Singapore ranks 39th of 85 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69 | 0.5 | 68.5 | Brazil |
| 2020s | 71.33 | 65.5 | 5.83 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Brazil or Singapore?
- Brazil, at 72 against 71 in Singapore as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Brazil and Singapore?
- 1, with Brazil ahead.
- How many years of comparable data are there for Brazil and Singapore?
- 10 years are reported by both, from 2016 to 2025.
- How do Brazil and Singapore rank globally for coverage of the human papillomavirus vaccine?
- Brazil ranks 36th and Singapore ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.